Pediatric health care: an introduction

LaVonn A Williams1

  • 1International Journal of Pharmaceutical Compounding, Edmond, Oklahoma 73034, USA. lwilliams@ijpc.com

Insights

Conducting pediatric drug studies is challenging but essential for safe and effective treatments. Building resources and expertise is crucial for advancing pediatric healthcare and compounding medications for children.

Area of Science:

  • Pediatric pharmacology and drug development.
  • Clinical trial design and execution in pediatric populations.
  • Compounded medication safety and efficacy.

Background:

  • Pediatric healthcare, including compounded medications, presents unique challenges for providers.
  • Existing research offers valuable insights into pediatric drug safety and effectiveness, but conducting studies in children remains difficult.
  • Specialized equipment, techniques, and child-sensitive specialists are necessary for pediatric research.

Purpose of the Study:

  • To highlight the difficulties in conducting pediatric clinical studies.
  • To emphasize the need for foundational resources and expertise in pediatric research.
  • To underscore the importance of reliable data for compounding medications for pediatric patients.

Main Methods:

  • This study is a review of the challenges and requirements for pediatric research.
  • It synthesizes current understanding of pediatric drug studies.
  • It identifies needs for future research infrastructure.

Main Results:

  • Pediatric studies require age-appropriate methods and sensitive specialists.
  • Developing a robust foundation and resources is critical for successful pediatric research.
  • Reliable data is essential for compounding pharmacists serving pediatric populations.

Conclusions:

  • Establishing dedicated resources and expertise is paramount for advancing pediatric drug research.
  • Improved research methodologies will enhance the safety and effectiveness of medications for children.
  • Collaboration between researchers and compounding pharmacists is vital for optimal pediatric patient care.

Related Concept Videos

Introduction To Health Care Delivery System01:18

Introduction To Health Care Delivery System

The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...